- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT01190540
Integrated Infectious Disease Capacity-Building Evaluation (IDCAP)
1. Dezember 2014 aktualisiert von: Marcia Weaver, University of Washington
Cost Effectiveness of Building Capacity of Mid-level Practitioners in Sub-Saharan Africa for the Care and Prevention of HIV, Tuberculosis, Malaria and Related Infectious Diseases
This evaluation aim is to investigate a cost-effective way to build capacity for the care and prevention of infectious diseases among mid-level practitioners (MLP) in sub-Saharan Africa.
Classroom based training continues to be the dominant form of training, despite evidence that suggests that on-site support (OSS) is more beneficial.
Definitive evidence that on-site support is the most effective way to deliver the required outputs and related outcomes is still lacking.
IDCAP will provide two interventions that integrate training in TB, HIV/AIDS and malaria as well as other infectious diseases, and the effects will be studied: 1) Integrated Management of Infectious Disease (IMID) training program for individual MLP, and 2) On-site support (OSS) for team of health professionals.
This study employs a mixed design with pre/post and cluster randomized trial components.
Interventions are at the level of the individual participant for IMID and at the level of the site (health facility) for OSS.
All participants attend a 3-week course, followed by two 1-week booster courses over a six month period.
After the 3-week course, a randomized arm of half the sampled facilities also received OSS every month for 9 months and bi-monthly for 6 additional months.
Studienübersicht
Status
Abgeschlossen
Detaillierte Beschreibung
There are four major components of the evaluation design as described below: 1) Site Assessment, 2) Competence and practice of individual MLP who participate in IDT, 3) Facility cost and performance indicators, and 4) Mortality survey.
The site assessment guided the curriculum development and site selection.
As shown in Figure 1, it occurred only once in Year 1.
The effect of the IMID and OSS on competence of individual MLP will be evaluated with written case scenarios or vignettes.
Data on case scenarios will be collected three times: a) before training, b) after the three-week course, and c) after the nine-month program that includes two, one-week booster courses and distance learning.
To estimate the effect of IMID, aggregate changes in test score across all 3 time points for both arms will be analyzed jointly.
To estimate the effect of OSS, differences in change in test score starting from after the three-week course to the end of the nine-month program will be compared across the 2 arms.
The effects on practice of individual trainees will be evaluated with clinical assessments by mobile team faculty during five outpatients visits and five HIV clinic visits by individual MLP.
Data on clinical assessments will be collected two times: a) before training, and b) after the nine-month program.
Facility performance indicators will be collected on a monthly basis from each site.
Sites will be randomly assigned to begin OSS in either Phase 1 or Phase 2 and the facility indicators of these two samples of sites will be compared.
The principal investigators of IDCAP are actively considering collecting data on mortality among children under five, but a final decision has not been made.
At the request of the acting chairperson of SOMREC, we are including information about this potential activity.
Mortality surveys would be conducted before and after the OSS.
Studientyp
Interventionell
Einschreibung (Tatsächlich)
72
Phase
- Unzutreffend
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienorte
-
-
-
Kampala, Uganda
- Infectious Disease Institute, Makerere University
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
- Kind
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Ja
Studienberechtigte Geschlechter
Alle
Beschreibung
Inclusion Criteria:
Facilities selected for OSS:
- The health facility had to be a HC IV or comparable facility such as a small general hospital or non-governmental organization clinic
- It had to be an active ART site or accredited ART site that is scheduled to become active by April 2009
- No past or current participation in a partnership with the U.S. Department of Defense
- Has a population of potential patients who are not prisoners
- Representation from all six administrative regions of Uganda
Exclusion Criteria:
- NA
MLP selected from the participating facilities for IMID:
Two mid-level practitioners (clinical officers, nurses, or midwives) who are actively engaged in clinical infectious-disease care will be selected for enrollment in IMID
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Versorgungsforschung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Aktiver Komparator: OSS Phase 1
Thirty-six sites will receive the On Site Support service (OSS) activities for nine to 15 months; 18 will be randomly assigned to receive the OSS in phase 1
|
On-Site-Support (OSS) service training will occur monthly for a period of 9 months.
This training and supervision will support the proper utilization of newly learned clinical skills.
The IMID is a 9-month training program that begins with a three-week course at the Infectious Diseases Institute (IDI) in Kampala Uganda.
After the course participants engage in 12 weeks of distance learning followed by a one-week boost course at the IDI.
Then the engage in 12 more weeks of distance learning and a final one-week boost course.
This intervention is offered to two clinicians (clinical officers or registered nurses or midwives) at every OSS Phase 1 and OSS Phase 2 site.
|
Aktiver Komparator: OSS Phase 2
Thirty-six sites will receive the OSS activities for nine to 15 months; 18 will be randomly assigned to receive the OSS in phase 2 that will serve as a control group in phase 1 and receive OSS nine months later.
|
The IMID is a 9-month training program that begins with a three-week course at the Infectious Diseases Institute (IDI) in Kampala Uganda.
After the course participants engage in 12 weeks of distance learning followed by a one-week boost course at the IDI.
Then the engage in 12 more weeks of distance learning and a final one-week boost course.
This intervention is offered to two clinicians (clinical officers or registered nurses or midwives) at every OSS Phase 1 and OSS Phase 2 site.
On-Site-Support (OSS) service training will occur monthly for a period of 9 to 15 months.
This training and supervision will support the proper utilization of newly learned clinical skills and continuous quality improvement of processes of care.
For the control group, the OSS training will occur during phase 2, after a randomly assigned wait list control period.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Model of Integrated Capacity Building Program
Zeitfenster: monthly over 3 years
|
The principal output of this evaluation will be a proven model of an integrated capacity-building package for the care and prevention of infectious disease in Africa.
The package will include a single curriculum for MLP and a portfolio of on-site support services founded on Accordia Global Health Foundation's considerable experience in training clinicians in North America and Africa.
|
monthly over 3 years
|
Competence of individual clinicians
Zeitfenster: 3 observations at pre/post IMID and final
|
Competence of individual clinicians will be measured by scores on 12 written case scenarios or vignettes.
Three blocks of 4 scenarios each covered different aspects of HIV/AIDS, tuberculosis, malaria, and other infectious diseases and included cases involving children, adults, and pregnant women.
Each case scenario addressed 6 principal domains: emergency or danger signs, history and physical examination, laboratory testing, diagnosis or classification of patients' medical problems; initial treatment or referral plan, and evolution of the case over time.
|
3 observations at pre/post IMID and final
|
Practice of individual clinicians
Zeitfenster: Baseline and Endline (9 months)
|
Clinical assessments will be conducted by mobile team faculty who will observe individual clinicians during five outpatient visits with children under five years and five HIV clinic visits.
Clinical practice will be assessed on history, physical examination, review of medical records (HIV clinic only), laboratory investigations ordered, diagnosis, treatment prescribed and patient education.
|
Baseline and Endline (9 months)
|
Clinical performance indicators
Zeitfenster: Monthly beginning 5 months before OSS
|
54 clinical performance indicators used by the Ministry of Health, the Uganda Malaria Surveillance Program or recommended by international organizations will be used to measure performance in general areas: 1) HIV prevention, 2) HIV care, 3) Antiretroviral therapy, 4) TB/HIV care, 5) Case management of respiratory infections, 6) Case Management of Fever, and 7) Emergency Triage and Treatment.
|
Monthly beginning 5 months before OSS
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Reduce Infection, Illness, and Mortality Rates
Zeitfenster: 3 years
|
The population in the areas surrounding the proposed sites will benefit directly from lower infection, illness and mortality rates.
The improved ability of clinic staff to deliver quality prevention and care services will increase access to cost-effective interventions delivered according to national guidelines by 9% to 25% depending on the intervention.
|
3 years
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Sponsor
Ermittler
- Hauptermittler: Marcia Weaver, PhD, University of Washington
- Hauptermittler: Sarah Naikoba, BMBCh, MPH, Infectious Disease Institute, Makarere University
Publikationen und hilfreiche Links
Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.
Allgemeine Veröffentlichungen
- Weaver M, Krieger J, Castorina J, et. al.
- World Health Organization. Generalized Cost-Effeciveness Analysis: A Guide. Geneva: World Health Organization, 2003. Available online at: http://www.who.int/choice/en/ Accessed on April 14, 2008.
- The Uganda Bureau of Statistics (UBOS), Macro International Inc., and MEASURE Evaluation. 2008. Uganda Child Verbal Autopsy Study 2007. Calverton, Maryland, USA: UBOS, Macro International Inc., and MEASURE Evaluation.
- Weaver MR, Crozier I, Eleku S, Makanga G, Mpanga Sebuyira L, Nyakake J, Thompson M, Willis K. Capacity-building and clinical competence in infectious disease in Uganda: a mixed-design study with pre/post and cluster-randomized trial components. PLoS One. 2012;7(12):e51319. doi: 10.1371/journal.pone.0051319. Epub 2012 Dec 14.
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn
1. November 2008
Primärer Abschluss (Tatsächlich)
1. August 2012
Studienabschluss (Tatsächlich)
1. August 2012
Studienanmeldedaten
Zuerst eingereicht
25. August 2010
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
25. August 2010
Zuerst gepostet (Schätzen)
27. August 2010
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
3. Dezember 2014
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
1. Dezember 2014
Zuletzt verifiziert
1. Dezember 2014
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 42657-EG
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Training and supervision
-
Karolinska InstitutetMinistry of Health and Social Affairs, SwedenAbgeschlossen
-
University of OklahomaRekrutierungAuswirkungen der Supervision auf den Lehrplan für Endoskopie-SimulationenVereinigte Staaten
-
WHO Collaborating Centre for Maternal and Child...CUAMM Doctors for AfricaUnbekanntUnterernährung, KindUganda
-
University of Wisconsin, MadisonAbgeschlossenPsychische GesundheitVereinigte Staaten
-
Children's Hospital Medical Center, CincinnatiAbgeschlossenAufmerksamkeits-Defizit-Hyperaktivitäts-StörungVereinigte Staaten
-
VA Office of Research and DevelopmentRekrutierungSchizophrenie | Bipolare Störung | Depressive Störung, Major | Belastungsstörung, posttraumatischVereinigte Staaten
-
Training and Implementation AssociatesRekrutierungTraditionelles Face-to-Face-Training | Trainings- und Implementierungsplattform für Familientherapie (FTTIP)Vereinigte Staaten
-
Nanyang Technological UniversityHCA Hospice CareUnbekannt
-
Samsung Medical CenterAbgeschlossenGangstörungen im AlterKorea, Republik von
-
Yun-Hee KimSamsung ElectronicsAbgeschlossenGangstörungen im AlterKorea, Republik von